Key result
Cardiac biomarker assay interferences are linked to documented clinical impact across 222 case reports.
Why the study?
What is the clinical impact of interferences with cardiac biomarker assays?
Population
222 case reports of interferences with cardiac biomarker assays published between January 1996 and July 2021
Authors
Loading...
Clinicians should scrutinize unexpected cardiac biomarker results for possible assay interference; leaves open true incidence and mitigation strategies.
What is the clinical impact of interferences with cardiac biomarker assays?
This review summarizes the clinical impact of interferences with cardiac biomarker assays based on 222 published case reports.
Nevraumont et al. (2021) studied this question. Interferences with cardiac biomarker assays have a documented clinical impact based on an analysis of 222 case reports published between 1996 and 2021.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: